GeneWize Expands DNA Customization into 3 Mega Markets

DNA Inspired Nutrition, Weight, & Skin Care Promise New Appeal from Large Consumer Base

Mar 28, 2011, 18:00 ET from GeneWize Life Sciences

ORLANDO, Fla., March 28, 2011 /PRNewswire/ -- GeneWize Life Sciences, Inc., a wholly owned subsidiary of GeneLink, Inc. (OTCQB: GNLK), has announced the world's first full-line of skin care products customized to an individual's DNA and the first gene-modulating weight management supplement to complement their revolutionary DNA customized nutritional supplement.  

Starting on March 12, GeneWize distributors were able to provide their customers a DNA personalized skin care system with six nutrient-rich products created just for one's skin genetic needs. Also on March 12, GeneWize distributors added to their product line a weight management supplement. This product modulates genes that affect metabolism, fat absorption and oxidation giving customers an edge in weight management that's not been available until now.

GeneWize President Sharon Tahaney explained: "The disruptive innovation of customizing products to an individual's personal genetics is just emerging, and is expected to have a significant impact on the combined $20 billion U.S. markets of skin care, weight management, and wellness supplements.   The addition of a full line of DNA personalized skin care products to the proven success of DNA nutrition along with a weight management supplement solidifies GeneLink and GeneWize as the consumer genetics early mover setting a new standard in personalized health and beauty. "

GeneLink, through GeneWize, was the first company to market products personalized through the world's hottest breakthrough technology – your DNA. In that short time, GeneWize has experienced over $20M in revenue. Mrs. Tahaney added: "In less than three years of marketing its DNA customized nutrition and skincare products, GeneWize is experiencing more than three times the typical expected customer loyalty among autoship models. GeneWize connects the dots between science and real world application, giving our wellness network a fresh solution to looking, feeling and living their best lives. The loyalty of our customers, the new competitive price range of our line, and the cutting edge science behind our products has given the GeneWize affiliate a true competitive advantage. Now, the extension of our product offerings, and the increasing awareness of the importance of consumer genetics is providing tremendous excitement as we move forward in 2011. We are eager to officially introduce our new lines, presentations and marketing support at our GeneWize annual event in Las Vegas in June."  

About GeneWize Life Sciences, Inc.:

GeneWize is a wholly owned subsidiary of GeneLink Biosciences, Inc. and the first network sales company to focus on providing individually customized nutritional and skin care formulations based on a consumer's personal DNA assessment. The company's mission is to empower individuals to take personal responsibility and control of their health. For more information visit

About GeneLink Biosciences, Inc.:

GeneLink is a 17-year old leading biosciences company specializing in consumer genomics. GeneLink's patented technologies include proprietary DNA test assessments linked to personalized health, beauty and wellness applications and products. Its DNA assessments provide information that enables the customization of nutritional and skincare products designed and manufactured to fulfill each individual consumer's wellness needs. For more information visit

This release contains certain forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. With the exception of historical information contained herein, the matters discussed in the press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward-looking statement. GeneLink disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future developments or otherwise.

SOURCE GeneWize Life Sciences